Patient organisation funding
Patient organisations – non-profit organisations founded by patients, care-givers, family members and health professionals – are important stakeholders for GSK.
They engage with healthcare providers, governments, the media, and patients to promote improved treatment and services for patients. They also campaign on issues that affect patients’ and care-givers’ lives, including increasing access to quality medicines, services and information on disease. Some carry out research into the causes of and potential treatments for specific conditions.
Pan European
During 2019-2021, we provided financial support to the following pan European patient organisations:
Agora (PDF-48.1KB)
Alzheimer Europe (PDF-194KB)
EUROPA DONNA - The European Breast Cancer Coalition (PDF-343KB)
European Cancer Patient Coalition (ECPC) (PDF-206KB)
European Federation of Allergy and Airways Disease Patients Association (PDF-677KB)
European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (PDF-210KB)
European Patients' Forum (EPF) (PDF-196KB)
Lupus Europe (PDF-209KB)
Myeloma Patients Europe (PDF-257KB)
Pulmonary Hypertension Association Europe (PDF-55.9KB)
Sarcoma Patients EuroNet (SPAEN) (PDF-343KB)
National European
Details of funding provided to patient organisations across Europe can be found on the relevant market website. Where no market website currently exists, and for those GSK local operating companies that supported patient organisations in 2021, the information is either published directly on this page or in a booklet available from the local office.
Markets with websites
Denmark
Finland
France
Germany
Italy
The Netherlands
Poland
Portugal
Spain
Markets without websites
Austria
BeLux (PDF-344KB)
Bulgaria (PDF-114KB)
Croatia (PDF-103KB)
Czech Republic (PDF-113KB)
Greece
Hungary (PDF-85.1KB)
Israel (PDF-234KB)
Latvia (PDF-148KB)
Lithuania (PDF-129KB)
Norway
Romania (PDF-101KB)
Serbia (PDF-159KB)
Slovakia (PDF-121KB)
Slovenia (PDF-147KB)
Sweden
Switzerland
Ukraine (PDF-104KB)
UK
During 2021, we provided support to the following UK patient organisations:
Asthma UK and British Lung Foundation Partnership (PDF-206KB)
Blood Cancer UK (PDF-203KB)
Cancer52 (PDF-199KB)
Croydon Vision (PDF-202KB)
Fifth sense (PDF-202 KB)
Hounslow Youth Counselling service (PDF-204KB)
Live Through This (PDF-3.94MB)
Lupus UK (PDF-3.94MB)
Meningitis Now (PDF-202KB)
MUMSAID (PDF-3.94MB)
Myeloma UK (PDF-204KB)
Ovacome (PDF-202KB)
Ovarian Cancer Action (PDF-200KB)
PBC (PDF-208KB)
Peaches (PDF-390KB)
Plasma of Hope (PDF-3.94MB)
Positive East (PDF-199KB)
Somerset and Wessex Eating Disorder Association (PDF-202KB)
Target Ovarian Cancer (PDF-203KB)
Youth@Heart (PDF-3.94MB)
GSK also provides funding to support UK community healthcare charities through the GSK IMPACT Awards, in partnership with The King’s Fund. This annual programme recognises and promotes excellence in community healthcare, providing funding and training to help strengthen the award winners’ current management plans and support their future aspirations.
Back to topEmerging Markets and Intercontinental
During 2021 we provided funding to the following emerging markets and intercontinental patient organisations:
Markets with websites
Brazil
Canada
Russia
South Korea
Turkey
Markets without websites
Argentina (PDF-557KB)
Colombia (PDF-220KB)
Chile (PDF-227KB)
Hong Kong (PDF-269KB)
New Zealand (PDF-217KB)
Taiwan (PDF-244KB)
Global
During 2019-2021, we provided financial support to the following global patient organisations:
Global Asthma and Allergy Patient Platform (GAAPP) (PDF-218KB)
International Alliance of Patient Organisations (IAPO) (PDF-210KB)
International Gynecologic Cancer Society (IGCS) (PDF-210KB)
International Myeloma Foundation (IMF) (PDF-264KB)
Meningitis Research Foundation (MRF) (PDF-212KB)
World Hepatitis Alliance (WHA) (PDF-392KB)
World Ovarian Cancer Coalition (WOCC) (PDF-213KB)
